NEPHSTROM

Researchers reveal cell therapy may reduce kidney damage from type 2 diabetes

According to researchers, a single dose of ORBCEL-M, given intravenously to carefully selected adults with worsening kidney disease due to diabetes was safe and associated with better preservation of kidney function compared to a placebo.